Fibroblast Growth Factor Receptor 3 Inhibits Osteoarthritis Progression in the Knee Joints of Adult Mice

Arthritis and Rheumatology

Volumn 68, Issue 10, 2016, Pages 2432-2443

  Tang, Junzhou ^a   Su, Nan ^a   Zhou, Siru ^a   Xie, Yangli ^a   Huang, Junlan ^a   Wen, Xuan ^a   Wang, Zuqiang ^a   Wang, Quan ^a   Xu, Wei ^a   Du, Xiaolan ^a   Chen, Hangang ^a   Chen, Lin ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 10; COLLAGEN TYPE 2; COLLAGENASE 3; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 3; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR RUNX2; ANILIDE; COL10A1 PROTEIN, MOUSE; COL2A1 PROTEIN, MOUSE; FGFR3 PROTEIN, MOUSE; IHH PROTEIN, MOUSE; MMP13 PROTEIN, MOUSE; PYRIDINE DERIVATIVE; RUNX2 PROTEIN, MOUSE; VISMODEGIB;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE DEGENERATION; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; FGFR3 GENE; GENE; GENE DELETION; GENE EXPRESSION; KNEE OSTEOARTHRITIS; MMP13 GENE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEPTOR GENE; RUNX2 GENE; SIGNAL TRANSDUCTION; UPREGULATION; ACHONDROPLASIA; ANIMAL; ANTAGONISTS AND INHIBITORS; CHONDROCYTE; COMPLICATION; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; GENETICS; IMMUNOHISTOCHEMISTRY; KNEE MENISCUS; KNOCKOUT MOUSE; MALE; METABOLISM; OSTEOARTHRITIS, KNEE; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SURGERY;

ACHONDROPLASIA; ANILIDES; ANIMALS; CARTILAGE, ARTICULAR; CHONDROCYTES; COLLAGEN TYPE II; COLLAGEN TYPE X; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DISEASE MODELS, ANIMAL; HEDGEHOG PROTEINS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 13; MENISCI, TIBIAL; MICE; MICE, KNOCKOUT; OSTEOARTHRITIS, KNEE; PYRIDINES; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; UP-REGULATION;

EID: 84988884542     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39739     Document Type: Article

References (57)

1. Chevalier X, Eymard F, Richette P. Biologic agents in osteoarthritis: hopes and disappointments. Nat Rev Rheumatol 2013;9:400–10.
2. Decker RS, Koyama E, Pacifici M. Genesis and morphogenesis of limb synovial joints and articular cartilage. Matrix Biol 2014;39:5–10.
3. Moon PM, Beier F. Novel insights into osteoarthritis joint pathology from studies in mice. Curr Rheumatol Rep 2015;17:50.
4. Du X, Xie Y, Xian CJ, Chen L. Role of FGFs/FGFRs in skeletal development and bone regeneration. J Cell Physiol 2012;227:3731–43.
5. Ornitz DM, Itoh N. The fibroblast growth factor signaling pathway. Wiley Interdiscip Rev Dev Biol 2015;4:215–66.
6. Xie Y, Zhou S, Chen H, Du X, Chen L. Recent research on the growth plate: advances in fibroblast growth factor signaling in growth plate development and disorders. J Mol Endocrinol 2014;53:T11–34.
7. Foldynova-Trantirkova S, Wilcox WR, Krejci P. Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias. Hum Mutat 2012;33:29–41.
8. Narayana J, Horton WA. FGFR3 biology and skeletal disease. Connect Tissue Res 2015:1–7.
9. Weng T, Yi L, Huang J, Luo F, Wen X, Du X, et al. Genetic inhibition of fibroblast growth factor receptor 1 in knee cartilage attenuates the degeneration of articular cartilage in adult mice. Arthritis Rheum 2012;64: 3982–92.
10. Li X, Ellman MB, Kroin JS, Chen D, Yan D, Mikecz K, et al. Species-specific biological effects of FGF-2 in articular cartilage: implication for distinct roles within the FGF receptor family. J Cell Biochem 2012;113:2532–42.
11. Shu CC, Jackson MT, Smith MM, Smith SM, Penm S, Lord MS, et al. Ablation of perlecan domain 1 heparan sulfate reduces progressive cartilage degradation, synovitis, and osteophyte size in a preclinical model of posttraumatic osteoarthritis. Arthritis Rheumatol 2016;68:868–79.
12. Valverde-Franco G, Binette JS, Li W, Wang H, Chai S, Laflamme F, et al. Defects in articular cartilage metabolism and early arthritis in fibroblast growth factor receptor 3 deficient mice. Hum Mol Genet 2006;15:1783–92.
13. Klag KA, Horton WA. Advances in treatment of achondroplasia and osteoarthritis. Hum Mol Genet 2016;25:R2–8.
14. Ni Q, Wang L, Wu Y, Shen L, Qin J, Liu Y, et al. Prenatal ethanol exposure induces the osteoarthritis-like phenotype in female adult offspring rats with a post-weaning high-fat diet and its intrauterine programming mechanisms of cholesterol metabolism. Toxicol Lett 2015;238:117–25.
15. Zhen G, Wen C, Jia X, Li Y, Crane JL, Mears SC, et al. Inhibition of TGF-β signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat Med 2013;19:704–12.
16. Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage 2013;21:16–21.
17. Valverde-Franco G, Liu H, Davidson D, Chai S, Valderrama-Carvajal H, Goltzman D, et al. Defective bone mineralization and osteopenia in young adult FGFR3−/− mice. Hum Mol Genet 2004;13:271–84.
18. Horton WA, Hall JG, Hecht JT. Achondroplasia. Lancet 2007;370:162–72.
19. Su N, Sun Q, Li C, Lu X, Qi H, Chen S, et al. Gain-of-function mutation in FGFR3 in mice leads to decreased bone mass by affecting both osteoblastogenesis and osteoclastogenesis. Hum Mol Genet 2010;19:1199–210.
20. Su N, Xu X, Li C, He Q, Zhao L, Li C, et al. Generation of Fgfr3 conditional knockout mice. Int J Biol Sci 2010;6:327–32.
21. Chen L, Adar R, Yang X, Monsonego EO, Li C, Hauschka PV, et al. Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis. J Clin Invest 1999;104:1517–25.
22. Iwata T, Chen L, Li C, Ovchinnikov DA, Behringer RR, Francomano CA, et al. A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos. Hum Mol Genet 2000;9:1603–13.
23. Chen M, Li S, Xie W, Wang B, Chen D. Col2CreER(T2), a mouse model for a chondrocyte-specific and inducible gene deletion. Eur Cell Mater 2014;28:236–45.
24. Glasson S, Blanchet T, Morris E. The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. Osteoarthritis Cartilage 2007;15:1061–9.
25. Glasson SS, Chambers MG, Van Den Berg WB, Little CB. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthritis Cartilage 2010;18 Suppl 3:S17–23.
26. Long F, Ornitz DM. Development of the endochondral skeleton. Cold Spring Harb Perspect Biol 2013;5:a008334.
27. Van der Kraan PM, van den Berg WB. Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration? Osteoarthritis Cartilage 2012;20:223–32.
28. Lotz M, Martel-Pelletier J, Christiansen C, Brandi ML, Bruyere O, Chapurlat R, et al. Value of biomarkers in osteoarthritis: current status and perspectives. Ann Rheum Dis 2013;72:1756–63.
29. Mak KK, Kronenberg HM, Chuang PT, Mackem S, Yang Y. Indian hedgehog signals independently of PTHrP to promote chondrocyte hypertrophy. Development 2008;135:1947–56.
30. Kobayashi T, Soegiarto DW, Yang Y, Lanske B, Schipani E, McMahon AP, et al. Indian hedgehog stimulates periarticular chondrocyte differentiation to regulate growth plate length independently of PTHrP. Journal Clinical Invest 2005;115:1734–42.
31. Lin AC, Seeto BL, Bartoszko JM, Khoury MA, Whetstone H, Ho L, et al. Modulating hedgehog signaling can attenuate the severity of osteoarthritis. Nat Med 2009;15:1421–U11.
32. Zhou J, Chen Q, Lanske B, Fleming BC, Terek R, Wei X, et al. Disrupting the Indian hedgehog signaling pathway in vivo attenuates surgically induced osteoarthritis progression in Col2a1-CreERT2; Ihhfl/fl mice. Arthritis Res Ther 2014;16:R11.
33. Chen L, Li C, Qiao W, Xu X, Deng C. A Ser365→Cys mutation of fibroblast growth factor receptor 3 in mouse downregulates Ihh/PTHrP signals and causes severe achondroplasia. Hum Mol Genet 2001;10:457–65.
34. Rockel JS, Alman BA. Don't hedge your bets: hedgehog signaling as a central mediator of endochondral bone development and cartilage diseases. J Orthop Res 2011;29:810–5.
35. Wang X, Manner PA, Horner A, Shum L, Tuan RS, Nuckolls GH. Regulation of MMP-13 expression by RUNX2 and FGF2 in osteoarthritic cartilage. Osteoarthritis Cartilage 2004;12:963–73.
36. Kamekura S, Kawasaki Y, Hoshi K, Shimoaka T, Chikuda H, Maruyama Z, et al. Contribution of runt-related transcription factor 2 to the pathogenesis of osteoarthritis in mice after induction of knee joint instability. Arthritis Rheum 2006;54:2462–70.
37. Higashikawa A, Saito T, Ikeda T, Kamekura S, Kawamura N, Kan A, et al. Identification of the core element responsive to runt-related transcription factor 2 in the promoter of human type X collagen gene. Arthritis Rheum 2009;60:166–78.
38. Rudin CM, Hann CL, Laterra J, Yauch RL, Callahan CA, Fu L, et al. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med 2009;361:1173–8.
39. Jiang Y, Tuan RS. Origin and function of cartilage stem/progenitor cells in osteoarthritis. Nat Rev Rheumatol 2015;11:206–12.
40. Ellman MB, Yan D, Ahmadinia K, Chen D, An HS, Im HJ. Fibroblast growth factor control of cartilage homeostasis. J Cell Biochem 2013;114:735–42.
41. Moore EE, Bendele AM, Thompson DL, Littau A, Waggie KS, Reardon B, et al. Fibroblast growth factor-18 stimulates chondrogenesis and cartilage repair in a rat model of injury-induced osteoarthritis. Osteoarthritis Cartilage 2005;13:623–31.
42. Mori Y, Saito T, Chang SH, Kobayashi H, Ladel CH, Guehring H, et al. Identification of fibroblast growth factor-18 as a molecule to protect adult articular cartilage by gene expression profiling. J Biol Chem 2014;289:10192–200.
43. Uchii M, Tamura T, Suda T, Kakuni M, Tanaka A, Miki I. Role of fibroblast growth factor 8 (FGF8) in animal models of osteoarthritis. Arthritis Res Ther 2008;10:R90.
44. Yan D, Chen D, Cool SM, van Wijnen AJ, Mikecz K, Murphy G, et al. Fibroblast growth factor receptor 1 is principally responsible for fibroblast growth factor 2-induced catabolic activities in human articular chondrocytes. Arthritis Res Ther 2011;13:R130.
45. Vincent TL. Fibroblast growth factor 2: good or bad guy in the joint? Arthritis Res Ther 2011;13:127.
46. Chia SL, Sawaji Y, Burleigh A, McLean C, Inglis J, Saklatvala J, et al. Fibroblast growth factor 2 is an intrinsic chondroprotective agent that suppresses ADAMTS-5 and delays cartilage degradation in murine osteoarthritis. Arthritis Rheum 2009;60:2019–27.
47. Sawaji Y, Hynes J, Vincent T, Saklatvala J. Fibroblast growth factor 2 inhibits induction of aggrecanase activity in human articular cartilage. Arthritis Rheum 2008;58:3498–509.
48. Yan D, Chen D, Im HJ. Fibroblast growth factor-2 promotes catabolism via FGFR1-Ras-Raf-MEK1/2-ERK1/2 axis that coordinates with the PKCδ pathway in human articular chondrocytes. J Cell Biochem 2012;113:2856–65.
49. Elsaid KA, Zhang L, Shaman Z, Patel C, Schmidt TA, Jay GD. The impact of early intra-articular administration of interleukin-1 receptor antagonist on lubricin metabolism and cartilage degeneration in an anterior cruciate ligament transection model. Osteoarthritis Cartilage 2015;23:114–21.
50. Horton WA. Bone and joint dysplasias. In: Klippel JH, Stone JH, Crofford LJ, White PH, editors. Primer on the rheumatic diseases. 13th ed. New York: Springer; 2008. p. 559–64.
51. Lotz M, Loeser RF. Effects of aging on articular cartilage homeostasis. Bone 2012;51:241–8.
52. Correa D, Somoza RA, Lin P, Greenberg S, Rom E, Duesler L, et al. Sequential exposure to fibroblast growth factors (FGF) 2, 9 and 18 enhances hMSC chondrogenic differentiation. Osteoarthritis Cartilage 2015;23:443–53.
53. Ellsworth JL, Berry J, Bukowski T, Claus J, Feldhaus A, Holderman S, et al. Fibroblast growth factor-18 is a trophic factor for mature chondrocytes and their progenitors. Osteoarthritis Cartilage 2002;10:308–20.
54. Zhou S, Xie Y, Tang J, Huang J, Huang Q, Xu W, et al. FGFR3 deficiency causes multiple chondroma-like lesions by upregulating hedgehog signaling. PLoS Genet 2015;11:e1005214.
55. Schibler L, Gibbs L, Benoist-Lasselin C, Decraene C, Martinovic J, Loget P, et al. New insight on FGFR3-related chondrodysplasias molecular physiopathology revealed by human chondrocyte gene expression profiling. PLoS One 2009;4:e7633.
56. Xu W, Xie Y, Wang Q, Wang X, Luo F, Zhou S, et al. A novel fibroblast growth factor receptor 1 inhibitor protects against cartilage degradation in a murine model of osteoarthritis. Sci Rep 2016;6:24042.
57. Wang Q, Green RP, Zhao G, Ornitz DM. Differential regulation of endochondral bone growth and joint development by FGFR1 and FGFR3 tyrosine kinase domains. Development 2001;128:3867–76.